March Biosciences (Series A)

Funding Details
Awarder
Inbox
Date Award
October 23, 2024
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$28,400,000

Company Info
Founders
Sarah Hein
Company Description
March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.
Market
Cancer Treatment
Location
Houston, Texas, USA
Coinvestors
4BIO Capital, Alexandria Venture Investments, Cancer Focus Fund, KdT Ventures, Mansueto Investments, Mission BioCapital, Modi Ventures, Portal Innovations, Small Ventures USA, TMC Venture Fund, Volnay Therapeutics

Links